Program Director's Message

On behalf of Dr. Anjlee Mahajan, the Associate Program Director, the Division of Hematology and Oncology at the UC (University of California) (University of California) Davis School of Medicine and the UC Davis Comprehensive Cancer Center, I would like to thank you for your interest in our Hematology and Oncology Fellowship Program.    

As a former fellow in the Hematology and Oncology Fellowship Program, I have a unique and personal perspective – this program provides a robust clinical foundation with an abundance of research opportunities in an incredibly collegial environment. It gave me a solid foundation to fulfill many of my career goals. Our graduates are successful in an array of environments, i.e., academia, integrated health systems, and private practice.  

The Division of Hematology and Oncology continues to be one of the largest divisions in the Department of Internal Medicine with 32 full-time faculty members. The UC Davis Comprehensive Cancer Center is the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in inland California, with a referral base of 4 million people hailing from an expansive region that stretches from the Oregon border to the lower San Joaquin Valley and to western Nevada. Our therapeutic programs, anchored by NCI-funded Phase I and Phase II development grants, offer pioneering therapies to patients.   Our mission is to train outstanding clinicians, clinician-scientists and translational researchers in hematology and oncology. The rotations that are offered in our program provide ample opportunities to take on a breadth of clinical problems across a diverse patient population at the UC Davis Medical Center and the VA (Veterans Affairs) Medical Center Sacramento.  

Research is a cornerstone of the program with a plethora of opportunities. Our fellows work with research mentors to accomplish their desired projects with many presenting at national meetings. For fellows interested in a clinical investigation career, our program offers the Mentored Clinical Research Training Program (MCRTP). Those who complete the program receive a Master of Advanced Study (MAS) in Clinical Research.  Other fellows who are interested in laboratory-based bench research also have a variety of options with active investigators within our own Division (i.e., T32 Training Program in Oncogenic Signals and Chromosome Biology).  

We believe our program offers a unique and comprehensive experience. Thank you for your interest in our fellowship program. We look forward to meeting you.


Mili Arora, MD

Mili Arora, M.D. 
Associate Professor of Medicine 
The Joe Sullivan Hematology Oncology Fellowship Program Director